Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.
(China AND ("Novel Coronavirus" OR COVID-19 OR SARS-CoV-2 OR 2019-nCoV))
4,628 results
  • Contributions of dermatologists to COVID-19 research: a brief systematic review. [Journal Article]
    Dermatol Ther. 2020 May 30 [Online ahead of print]Wang Y, Fang R, … Sun Q
  • Coronavirus Disease 2019 (COVID-19) has been declared a pandemic. We conducted a systematic review to reveal the contribution of dermatologists in COVID-19 research. 298 articles were included and classified into cutaneous manifestations of COVID-19, operating experience against COVID-19, mechanisms and treatment of COVID-19, disinfection and personal protective equipment(PPE)-related skin diseas…
  • The Clinics of HHV-6 infection in COVID-19 pandemic: Pityriasis rosea and Kawasaki disease. [Journal Article]
    Dermatol Ther. 2020 May 31 [Online ahead of print]Dursun R, Temiz SA
  • A new type of coronavirus family (SARS-CoV-2), which can be found in humans and animals, with many varieties and clinical symptoms, was first seen in Wuhan, China in late 2019, under the name novel Coronavirus Disease 2019 (COVID-19). In the literature, cutaneous symptoms related to the disease are generally emphasized. However, it is not yet known whether this new SARS-CoV-2 virus, which has ent…
  • Children's heart and COVID-19: Up-to-date evidence in the form of a systematic review. [Review]
    Eur J Pediatr. 2020 May 30 [Online ahead of print]Sanna G, Serrau G, … Marcialis MA
  • CONCLUSIONS: This systematic review is aimed at summarizing all COVID-19 cases with a cardiac involvement published in paediatric age and trying to explain the underlying mechanisms responsible for COVID-19-related myocardial damage.What is Known:• Coronaviruses proved to be able to jump from animals to humans.• The outbreak of COVID-19 started from China (Dec 2019) and became pandemic.What is New:• Even in childhood, COVID-19 is not without the risk of cardiac involvement.• Myocarditis, heart failure, and arrhythmias are among the possible manifestations.
  • Relationship between clinical types and radiological subgroups defined by latent class analysis in 2019 novel coronavirus pneumonia caused by SARS-CoV-2. [Journal Article]
    Eur Radiol. 2020 May 30 [Online ahead of print]Fang X, Li X, … Lu J
  • CONCLUSIONS: The demographic and clinical differences between the two radiological subgroups based on the LCA were significantly different. Two radiological subgroups were significantly associated with clinical moderate and severe types.• Two radiological subgroups were identified using LCA. • Older age, therapy, presence of fever, presence of hypertension, decreased lymphocyte count, and increased CRP levels were significant parameters with an increased risk for class 2 defined by LCA. • Patients with clinically severe type had a 1.97-fold higher risk of class 2 defined by LCA in comparison with patients showing clinically moderate-type disease.
  • Clinical characteristics and chest CT imaging features of critically ill COVID-19 patients. [Journal Article]
    Eur Radiol. 2020 May 30 [Online ahead of print]Zhang N, Xu X, … Sun Z
  • CONCLUSIONS: Older patients with comorbidities such as diabetes and emphysema, and higher CRP and NLRs with diffuse lung involvement were more likely to die of COVID-19.• Almost all patients critically ill with COVID-19 pneumonia had five lung lobes involved. • Medial or parahilar area involvement and degree of lung involvement were more serious in the deceased patients when compared with those who recovered from treatment. • Chronic lung disease, e.g., emphysema, diabetes, and higher serum CRP and NLR characterized patients who died of COVID-19.
  • Pharmacy services at a temporary COVID-19 hospital in Wuhan, China. [Journal Article]
    Am J Health Syst Pharm. 2020 May 31 [Online ahead of print]Wu J, Shen B, … Zhou B
  • In an effort to expedite the publication of articles related to the COVID-19 pandemic, AJHP is posting these manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (fo…
  • Oral saliva and CVID-19. [Review]
    Oral Oncol. 2020 May 27; 108:104821.Baghizadeh Fini M
  • Outbreak pneumonia announced in Wuhan, China, in December 2019, had its causative factor classified as a new coronavirus (SARS-CoV-2). Since saliva can host several viruses including SARS-CoV-2, the transmission chance of viruses through saliva, particularly those causing respiratory infections, is unavoidable. COVID-19 can be detected through salivary diagnostic testing which has lots of advanta…
  • Neurosurgery Practice During Coronavirus Disease 2019 (COVID-19) Pandemic. [Review]
    World Neurosurg. 2020 May 28 [Online ahead of print]Ozoner B, Gungor A, … Kilic T
  • Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a highly contagious, life-threatening condition with unprecedented impacts for worldwide societies and healthcare systems. Since the first detection in China, it has spread rapidly worldwide. The increased burden has substantially impacted the neurosurgery practice and intensive modific…
  • SARS-CoV-2 and COVID-19: A genetic, epidemiological, and evolutionary perspective. [Review]
    Infect Genet Evol. 2020 May 28 [Online ahead of print]Sironi M, Hasnain SE, … Editors of Infection, Genetics and Evolution
  • In less than five months, COVID-19 has spread from a small focus in Wuhan, China, to more than 5 million people in almost every country in the world, dominating the concern of most governments and public health systems. The social and political distresses caused by this epidemic will certainly impact our world for a long time to come. Here, we synthesize lessons from a range of scientific perspec…
  • Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research. [Journal Article]
    Thromb Haemost. 2020 May 30 [Online ahead of print]Bikdeli B, Madhavan MV, … Global COVID-19 Thrombosis Collaborative Group
  • Coronavirus disease 2019 (COVID-19), currently a worldwide pandemic, is a viral illness caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The suspected contribution of thrombotic events to morbidity and mortality in COVID-19 patients has prompted a search for novel potential options for preventing COVID-19-associated thrombotic disease. In this article by the Global COVI…
  • The need for fully bio-based facemasks to counter coronavirus outbreaks: A perspective. [Journal Article]
    Sci Total Environ. 2020 May 22; 736:139611.Das O, Neisiany RE, … Ramakrishna S
  • The onset of coronavirus pandemic has sparked a shortage of facemasks in almost all nations. Without this personal protective equipment, healthcare providers, essential workers, and the general public are exposed to the risk of infection. In light of the aforementioned, it is critical to balance the supply and demand for masks. COVID-19 will also ensure that masks are always considered as an esse…
  • A review of South Indian medicinal plant has the ability to combat against deadly viruses along with COVID-19? [Journal Article]
    Microb Pathog. 2020 May 27 [Online ahead of print]Divya M, Vijayakumar S, … Durán-Lara EF
  • SARS-CoV2 is a source of coronavirus infectious disease (COVID-19), this is considered as a fatal disease to universal communal health apprehension. This rapid pathogenic virus plays an important role in finding the pathogenic virus, treatment and prevention of pandemics. Virus can present everywhere in Global village. As it is virus it can extend easily and cause severe illness to the society. H…
New Search Next